Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OPKO Health Inc (NASDAQ:OPK)

10.87
Delayed Data
As of 3:59pm ET
 -0.32 / -2.86%
Today’s Change
7.12
Today|||52-Week Range
11.85
+8.16%
Year-to-Date
Insiders Cannot Get Enough Of Endurance International And Opko Health
9:44am / Benzinga - Paid Partner Content
Weekly CEO Buys Highlights
Sep 26 / GuruFocus News - Paid Partner Content
Opko Health Has Big News on Deck
Sep 27 / MotleyFool.com - Paid Partner Content
3 Stocks That Turned $5,000 Into $50,000 or More
Sep 15 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close11.19
Today’s open11.17
Day’s range10.83 - 11.18
Volume3,811,492
Average volume (3 months)3,287,690
Market cap$6.2B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)+85.37%
Earnings growth (this year)-23.33%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+439.63%
P/E ratio36.9
Price/Sales9.97
Price/Book3.08

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...-1.42-1.82%
TSROTESARO Inc-3.62-3.35%
UTHRUnited Therapeutics ...-3.34-2.74%
ENDPEndo International P...-0.17-0.75%
Data as of 4:14pm ET, 09/28/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$491.7M
Annual profit (last year)-$30.0M
Net profit margin-6.11%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Phillip Frost
Chief Financial Officer, Treasurer, CAO &
SVP
Adam E. Logal
Corporate headquarters
Miami, Florida

Forecasts

Search for Jobs